ANALYSTRatingvia Quantisnow
Compass Therapeutics Inc. logo

Citizens JMP initiated coverage on Compass Therapeutics with a new price target

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for CMPX

Across the 5 sessions after earlier CMPX headlines, the stock closed higher 4 times and lower 0 times, with a median move of 1.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Keep researching CMPX

Quantisnow market dataNASDAQ
Compass Therapeutics Inc. logo
CMPX
Compass Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for CMPX

Follow CMPX and get a push notification the moment its next story breaks.

Full CMPX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMPX (Compass Therapeutics Inc.) and more on Quantisnow.